Impact of atrial fibrillation on NT-proBNP levels in a 75-year-old population

References

• Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention. The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. J Am Med Assoc. 2001; 285:2370–5.
   PubMed Web of Science ®Google Scholar
• Heeringa J, van der Kuip DA, Hofman A, Kors JA, van HG, Stricker BH, Stijnen T, Lip GY, Witteman JC. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006; 27:949–53.
   PubMed Web of Science ®Google Scholar
• Tveit A, Abdelnoor M, Enger S, Smith P. Atrial fibrillation and antithrombotic therapy in a 75-year-old population. Cardiology. 2008; 109:258–62.
   PubMed Web of Science ®Google Scholar
• Hall C. NT-ProBNP: the mechanism behind the marker. J Card Fail. 2005; 115 Suppl:S81–3.
   PubMed Web of Science ®Google Scholar
• Knudsen CW, Omland T, Clopton P, Westheim A, Wu AH, Duc P, McCord J, Nowak RM, Hollander JE, Storrow AB, Abraham WT, McCullough PA, Maisel A. Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients: an analysis from the breathing not properly multinational study. J Am Coll Cardiol. 2005; 46:838–44.
   PubMed Web of Science ®Google Scholar
• Shin DI, Jaekel K, Schley P, Sause A, Muller M, Fueth R, Scheffold T, Guelker H, Horlitz M. Plasma levels of NT-pro-BNP in patients with atrial fibrillation before and after electrical cardioversion. Z Kardiol. 2005; 94:795–800.
   PubMedGoogle Scholar
• Silvet H, Young-Xu Y, Walleigh D, Ravid S. Brain natriuretic peptide is elevated in outpatients with atrial fibrillation. Am J Cardiol. 2003; 92:1124–7.
   PubMed Web of Science ®Google Scholar
• Inoue S, Murakami Y, Sano K, Katoh H, Shimada T. Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation. J Card Fail. 2000; 6:92–6.
   PubMed Web of Science ®Google Scholar
• Asselbergs FW, van den Berg MP, Bakker SJ, Signorovitch JE, Hillege HL, van Gilst WH, van Veldhuisen. N-terminal pro B-type natriuretic peptide levels predict newly detected atrial fibrillation in a population-based cohort. Neth Heart J. 2008; 16:73–8.
   PubMed Web of Science ®Google Scholar
• Hou JL, Gao K, Li M, Ma JY, Shi YK, Wang Y, Zhao YF. Increased N-terminal pro-brain natriuretic peptide level predicts atrial fibrillation after surgery for esophageal carcinoma. World J Gastroenterol. 2008; 14:2582–5.
   PubMed Web of Science ®Google Scholar
• Cardinale D, Colombo A, Sandri MT, Lamantia G, Colombo N, Civelli M, Salvatici M, Veronesi G, Veglia F, Fiorentini C, Spaggiari L, Cipolla CM. Increased perioperative N-terminal pro-B-type natriuretic peptide levels predict atrial fibrillation after thoracic surgery for lung cancer. Circulation. 2007; 115:1339–44.
   PubMed Web of Science ®Google Scholar
• Watanabe D, Shizuka K, Koyama S. IwamotoT Plasma brain natriuretic peptide levels indicating thromboembolism in very elderly patients with non-valvular atrial fibrillation. Circ J. 2007; 71:1446–51.
   PubMed Web of Science ®Google Scholar
• Shimizu H, Murakami Y, Inoue S, Ohta Y, Nakamura K, Katoh H, Sakne T, Takahashi N, Ohata S, Sugamori T, Ishibashi Y, Shimada T. High plasma brain natriureticpolypeptide level as a marker of risk for thromboembolism in patients with nonvalvular atrial fibrillation. Stroke. 2002; 33:1005–10.
   PubMed Web of Science ®Google Scholar
• Beck-da-Silva L, de BA, Fraser M, Williams K, Haddad H. Brain natriuretic peptide predicts successful cardioversion in patients with atrial fibrillation and maintenance of sinus rhythm. Can J Cardiol. 2004; 20:1245–8.
   PubMed Web of Science ®Google Scholar
• Tveit A, Seljeflot I, Grundvold I, Abdelnoor M, Arnesen H, Smith P. Candesartan, NT-proBNP and recurrence of atrial fibrillation after electrical cardioversion. Int J Cardiol. 2009; 1312:234–9.
   PubMed Web of Science ®Google Scholar
• Lellouche N, Berthier R, Mekontso-Dessap A, Braconnier F, Monin JL, Duval AM, Dubois-Rande JL, Gueret P, Garot J. Usefulness of plasma B-type natriuretic peptide in predicting recurrence of atrial fibrillation one year after external cardioversion. Am J Cardiol. 2005; 95:1380–2.
   PubMed Web of Science ®Google Scholar
• Lombardi F, Tundo F, Belletti S, Mantero A, Melzi D'eril GV. C-reactive protein but not atrial dysfunction predicts recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function. J Cardiovasc Med (Hagerstown). 2008; 9:581–8.
   PubMed Web of Science ®Google Scholar
• Mabuchi N, Tsutamoto T, Maeda K, Kinoshita M. Plasma cardiac natriuretic peptides as biochemical markers of recurrence of atrial fibrillation in patients with mild congestive heart failure. Jpn Circ J. 2000; 64:765–71.
   PubMedGoogle Scholar
• Costello-Boerrigter LC, Boerrigter G, Redfield MM, Rodeheffer RJ, Urban LH, Mahoney DW, Jacobsen SJ, Heublein DM, Burnett JC Jr, . Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction. J Am Coll Cardiol. 2006; 47:345–53.
   PubMed Web of Science ®Google Scholar
• Galasko GI, Lahiri A, Barnes SC, Collinson P. Senior R What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease. Eur Heart J. 2005; 26:2269–76.
   PubMed Web of Science ®Google Scholar
• Wallen T, Landahl S, Hedner T, Nakao K, Saito Y. Brain natriuretic peptide predicts mortality in the elderly. Heart. 1997; 77:264–7.
   PubMed Web of Science ®Google Scholar
• Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004; 350:655–63.
   PubMed Web of Science ®Google Scholar
• Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976; 16:31–41.
   PubMed Web of Science ®Google Scholar
• Vinch CS, Rashkin J, Logsetty G, Tighe DA, Hill JC, Meyer TE, Rosenthal LS. Aurigemma GP Brain natriuretic peptide levels fall rapidly after cardioversion of atrial fibrillation to sinus rhythm. Cardiology. 2004; 102:188–93.
   PubMed Web of Science ®Google Scholar
• Tsuchida K, Tanabe K. Influence of paroxysmal atrial fibrillation attack on brain natriuretic peptide secretion. J Cardiol. 2004; 44:1–11.
   PubMedGoogle Scholar
• Wozakowska-Kaplon B, Opolski G. Effects of sinus rhythm restoration in patients with persistent atrial fibrillation: a clinical, echocardiographic and hormonal study. Int J Cardiol. 2004; 96:171–6.
   PubMed Web of Science ®Google Scholar
• Loke I, Squire IB, Davies JE, Ng LL. Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate. Eur J Heart Fail. 2003; 5:599–606.
   PubMed Web of Science ®Google Scholar
• Krauser DG, Lloyd-Jones DM, Chae CU, Cameron R, Anwaruddin S, Baggish AL, Chen A, Tung R, Januzzi JL Jr, . Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) sub study. Am Heart J. 2005; 149:744–50.
   PubMed Web of Science ®Google Scholar
• Bayes-Genis A, DeFilippi C, Januzzi JL Jr, . Understanding amino-terminal pro-B-type natriuretic peptide in obesity. Am J Cardiol. 2008; 1013A:89–94.
   PubMed Web of Science ®Google Scholar
• Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PW, Vasan RS. Impact of obesity on plasma natriuretic peptide levels. Circulation. 2004; 109:594–600.
   PubMed Web of Science ®Google Scholar
• Tagore R, Ling LH, Yang H, Daw HY, Chan YH, Sethi SK. Natriuretic Peptides in Chronic Kidney Disease. Clin J Am Soc Nephrol. 2008; 36:1644–51.
   PubMed Web of Science ®Google Scholar
• Davis ME, Richards AM, Nicholls MG, Yandle TG, Frampton CM, Troughton RW. Introduction of metoprolol increases plasma B-type cardiac natriuretic peptides in mild, stable heart failure. Circulation. 2006; 113:977–85.
   PubMed Web of Science ®Google Scholar